[{"address1": "4995 Murphy Canyon Road", "address2": "Suite 300", "city": "San Diego", "state": "CA", "zip": "92123", "country": "United States", "phone": "760 471 8536", "website": "https://www.conduitpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Conduit Pharmaceuticals Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis and Grave's disease, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. The company was founded in 2019 and is based in San Diego, California. Conduit Pharmaceuticals Limited is a subsidiary of Corvus Capital Limited.", "fullTimeEmployees": 7, "companyOfficers": [{"maxAge": 1, "name": "Dr. David Joszef Tapolczay", "age": 64, "title": "CEO & Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 419799, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. James  Bligh", "age": 34, "title": "Interim CFO & Director", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 533345, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Joanne M. Holland", "age": 48, "title": "Chief Scientific Officer", "yearBorn": 1975, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bill  Begien", "title": "Senior VP of Investor Relations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.6401, "open": 0.72, "dayLow": 0.5075, "dayHigh": 0.7961, "regularMarketPreviousClose": 0.6401, "regularMarketOpen": 0.72, "regularMarketDayLow": 0.5075, "regularMarketDayHigh": 0.7961, "beta": 2.196, "volume": 363636, "regularMarketVolume": 363636, "averageVolume": 104822, "averageVolume10days": 427850, "averageDailyVolume10Day": 427850, "bid": 0.5118, "ask": 0.5704, "bidSize": 100, "askSize": 100, "marketCap": 39203468, "fiftyTwoWeekLow": 0.507, "fiftyTwoWeekHigh": 25.0, "fiftyDayAverage": 2.4499, "twoHundredDayAverage": 3.30263, "currency": "USD", "enterpriseValue": 38654484, "floatShares": 19390589, "sharesOutstanding": 73829504, "sharesShort": 56774, "sharesShortPriorMonth": 34103, "sharesShortPreviousMonthDate": 1715731200, "dateShortInterest": 1718323200, "sharesPercentSharesOut": 0.0008, "heldPercentInsiders": 0.86654, "heldPercentInstitutions": 0.02243, "shortRatio": 0.92, "impliedSharesOutstanding": 73829504, "bookValue": -0.042, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -2415000, "trailingEps": -0.03, "52WeekChange": -0.95055866, "SandP52WeekChange": 0.26253593, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "CDT", "underlyingSymbol": "CDT", "shortName": "Conduit Pharmaceuticals Inc.", "longName": "Conduit Pharmaceuticals Inc.", "firstTradeDateEpochUtc": 1648474200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a0dccb0b-a2b5-3d84-a45d-30dad465afbd", "messageBoardId": "finmb_1772079937", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.531, "recommendationKey": "none", "totalCash": 1844000, "totalCashPerShare": 0.025, "totalDebt": 1295000, "quickRatio": 0.929, "currentRatio": 1.591, "returnOnAssets": -1.69929, "freeCashflow": -7966875, "operatingCashflow": -8112000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-07-08"}]